SurvBenchmark
SurvBenchmark evaluates survival analysis methods across censored omics and clinical datasets to quantify and compare model predictability, stability, flexibility, and computational efficiency.
Key Features:
- Diverse Model Evaluation: Evaluates a wide array of survival models, including the Cox model and machine-learning–based survival approaches.
- Multi-Metric Assessment: Assesses models using multiple performance metrics: predictability, stability, flexibility, and computational efficiency.
- Systematic Comparison Design: Performs 320 comparisons across 20 methods and 16 datasets.
- Real-World Variability Analysis: Highlights variability in model performance across datasets and metrics relevant to translational scientists and clinicians.
- Guidance for Future Research: Identifies areas for further investigation in survival analysis techniques and benchmarking strategies.
Scientific Applications:
- Translational research: Supports integration of omics and clinical data to select prognostic models for personalized treatment strategies.
- Method selection and benchmarking: Provides comparative evidence to guide selection of appropriate survival models for specific datasets and study goals.
Methodology:
Benchmarks 20 methods across 16 datasets with 320 systematic comparisons, evaluating each model using multiple metrics (predictability, stability, flexibility, computational efficiency) and including Cox and machine-learning–based survival models.
Topics
Details
- License:
- Apache-2.0
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 9/28/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Zhang Y, Wong G, Mann G, Muller S, Yang JYH. SurvBenchmark: comprehensive benchmarking study of survival analysis methods using both omics data and clinical data. GigaScience. 2022;11. doi:10.1093/gigascience/giac071. PMID:35906887. PMCID:PMC9338425.
PMID: 35906887
PMCID: PMC9338425
Funding: - Australian Research Council: DP210100521
- National Health and Medical Research Council's CRE: APP1135285